Pharmacotherapeutic Management of Cardiovascular Disease Complications :: a textbook for medical students.
Pharmacotherapeutic Management of Cardiovascular Disease Complications is an essential textbook which comprehensively informs the reader about a broad variety of cardiovascular pathologies and their management through drug therapy. Key Features:- Features 22 chapters, with 17 chapters dedicated to t...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Electronic eBook |
| Language: | English |
| Published: |
Singapore :
Bentham Science Publishers,
[2020]
|
| Subjects: | |
| Online Access: | DE-862 DE-863 |
| Summary: | Pharmacotherapeutic Management of Cardiovascular Disease Complications is an essential textbook which comprehensively informs the reader about a broad variety of cardiovascular pathologies and their management through drug therapy. Key Features:- Features 22 chapters, with 17 chapters dedicated to the management of a wide range of cardiomyopathies and related complications- Introduces readers to heart anatomy and physiology, for both medical and pharmacology students- Covers information on cardiovascular disease biomarkers as well as current and new technologies for diagnostic procedures- Prov. |
| Item Description: | Cardiac Stress Test. |
| Physical Description: | 1 online resource (361 pages) |
| ISBN: | 9789811468216 9811468214 |
Staff View
MARC
| LEADER | 00000cam a2200000 i 4500 | ||
|---|---|---|---|
| 001 | ZDB-4-EBA-on1202481001 | ||
| 003 | OCoLC | ||
| 005 | 20250103110447.0 | ||
| 006 | m o d | ||
| 007 | cr cnu---unuuu | ||
| 008 | 201031s2020 si o 000 0 eng d | ||
| 040 | |a EBLCP |b eng |e rda |e pn |c EBLCP |d YDX |d N$T |d OCLCO |d N$T |d OCLCF |d YDX |d OCLCO |d OCLCQ |d K6U |d OCLCQ |d OCLCO |d OCLCL |d SXB |d CLOUD | ||
| 019 | |a 1198713468 |a 1202448652 | ||
| 020 | |a 9789811468216 |q (electronic book) | ||
| 020 | |a 9811468214 |q (electronic book) | ||
| 035 | |a (OCoLC)1202481001 |z (OCoLC)1198713468 |z (OCoLC)1202448652 | ||
| 050 | 4 | |a RC667 |b .K86 2020 | |
| 082 | 7 | |a 616.1/061 |2 23 | |
| 049 | |a MAIN | ||
| 100 | 1 | |a Kumar, A. Bharath. | |
| 245 | 1 | 0 | |a Pharmacotherapeutic Management of Cardiovascular Disease Complications : |b a textbook for medical students. |
| 264 | 1 | |a Singapore : |b Bentham Science Publishers, |c [2020] | |
| 300 | |a 1 online resource (361 pages) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 505 | 0 | |a Cover -- Title -- Copyright -- End User License Agreement -- Contents -- Preface -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- Introduction to Heart Anatomy and Physiology -- INTRODUCTION -- Location of Heart -- Size and Shape of the Heart -- Chambers and Blood Circulation in the Heart -- Heart Chambers -- Blood Vessels -- Heart valves -- ANATOMY OF HEART -- Left Side of the Heart -- Right Side of the Heart -- Covering Layers of Heart -- The Internal Structural Pattern of the Heart -- Right Atrium -- Left Atrium -- Right Ventricle -- Left ventricle | |
| 505 | 8 | |a PHYSIOLOGY OF THE HEART -- Diastole -- Conduction System of the Heart -- Cardiac Cycle -- Relaxation Phase -- Blood Supply to Heart -- Heart Sounds -- Cardiac Output -- CONCLUSION -- REFERENCES -- Role of Biomarkers in Detection of Cardiovascular Diseases -- INTRODUCTION -- IDEAL CHARACTERISTICS OF BIOMARKERS -- MYOCARDIUM INJURY RISK PREDICTION BIOMARKERS -- Cardiac Troponin -- High-Sensitivity Cardiac Troponin (hs-cTn) -- Heart-Type Fatty Acid Binding Protein (H-FABP) -- INFLAMMATION PREDICTION BIOMARKERS -- High-Sensitivity C-reactive Protein (hs-CRP) | |
| 505 | 8 | |a Growth-Differentiation Factor-15 (GDF-15) -- Fibrinogen -- Uric Acid -- PLAQUES RUPTURE ASSESSMENT BIOMARKERS -- Myeloperoxidase (MPO) -- Matrix Metalloproteinases -- Pregnancy-Associated Plasma Protein-A (PAPP-A) -- Platelet Activation Biomarkers -- Secretory Phospholipase A2 (sPLA2) -- Lipoprotein-Associated Phospholipase A2 -- Soluble CD40 Ligand (sCD40L) -- BIOMARKERS OF NEUROHORMONAL ACTIVATION -- Mid-Regional-Pro-Adrenomedullin -- MYOCARDIAL DYSFUNCTION DETECTION BIOMARKERS ST -- Endothelin-1 (ET-1) -- Galectin-3 -- Neuregulin-1 -- BIOMARKERS OF MICRO RNAS (MIRNAS) | |
| 505 | 8 | |a OTHER BIOMARKERS INVOLVED IN THE PREDICTION OF CARDIOVASCULAR DISEASE RISK PREDICTION -- Neutrophil Gelatinase-Associated Lipocalin -- Natriuretic Peptides -- Apelin -- Growth Differentiation Factor-15 -- Cyclophilin A -- Prolactin -- Heart-type Fatty Acid Binding Protein (H-FABP) -- CONCLUSION -- REFERENCES -- Diagnostic Investigations for Detection of Cardiovascular Diseases -- INTRODUCTION -- CARDIOVASCULAR DISEASES: A GROUP OF DISORDERS OF THE HEART AND BLOOD VESSELS -- Coronary Heart Disease -- Cerebrovascular Disease -- Peripheral Arterial Disease -- Rheumatic Heart Disease | |
| 505 | 8 | |a Congenital Heart Disease -- Deep Vein Thrombosis and Pulmonary Embolism -- RISK FACTORS FOR CARDIOVASCULAR DISEASE -- DIAGNOSTIC INVESTIGATIONS FOR CARDIOVASCULAR DISEASES -- Blood Analysis -- Biomarkers for Detection of Cardiovascular Disease -- B-type Natriuretic Peptides -- Blood Urea Nitrogen -- C-reactive Protein -- Enzymes -- Fibrinogen -- Blood Sugar Test -- Homocysteine -- Lipid -- OTHER CARDIOVASCULAR DISEASE DIAGNOSTIC INVEST-IGATIONS -- CT Scan -- Cardiac Catheterization -- Echocardiography -- Ejection Fraction Testing -- Electrocardiogram -- Electrophysiology Study | |
| 500 | |a Cardiac Stress Test. | ||
| 520 | |a Pharmacotherapeutic Management of Cardiovascular Disease Complications is an essential textbook which comprehensively informs the reader about a broad variety of cardiovascular pathologies and their management through drug therapy. Key Features:- Features 22 chapters, with 17 chapters dedicated to the management of a wide range of cardiomyopathies and related complications- Introduces readers to heart anatomy and physiology, for both medical and pharmacology students- Covers information on cardiovascular disease biomarkers as well as current and new technologies for diagnostic procedures- Prov. | ||
| 650 | 0 | |a Cardiovascular system |x Diseases |x Chemotherapy. | |
| 650 | 6 | |a Appareil cardiovasculaire |x Maladies |x Chimiothérapie. | |
| 650 | 7 | |a Cardiology. |2 bisacsh/2013 | |
| 650 | 7 | |a MEDICAL. |2 bisacsh/2013 | |
| 650 | 7 | |a Cardiovascular system |x Diseases |x Chemotherapy |2 fast | |
| 655 | 0 | |a Electronic books. | |
| 655 | 4 | |a Electronic book. | |
| 700 | 1 | |a Umashankar, M. S. | |
| 758 | |i has work: |a Pharmacotherapeutic Management of Cardiovascular Disease Complications: A Textbook for Medical Students (Text) |1 https://id.oclc.org/worldcat/entity/E39PCXjfjb6FtGtxJ4YdMYphgX |4 https://id.oclc.org/worldcat/ontology/hasWork | ||
| 776 | 0 | 8 | |i Print version: |a Umashankar, M.S. |t Pharmacotherapeutic Management of Cardiovascular Disease Complications: a Textbook for Medical Students. |d Singapore : Bentham Science Publishers, ©2020 |z 9789811468193 |
| 966 | 4 | 0 | |l DE-862 |p ZDB-4-EBA |q FWS_PDA_EBA |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=2636075 |3 Volltext |
| 966 | 4 | 0 | |l DE-863 |p ZDB-4-EBA |q FWS_PDA_EBA |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=2636075 |3 Volltext |
| 938 | |a cloudLibrary |b CLDL |n 9789811468216 | ||
| 938 | |a ProQuest Ebook Central |b EBLB |n EBL6371155 | ||
| 938 | |a EBSCOhost |b EBSC |n 2636075 | ||
| 938 | |a YBP Library Services |b YANK |n 301580035 | ||
| 994 | |a 92 |b GEBAY | ||
| 912 | |a ZDB-4-EBA | ||
| 049 | |a DE-862 | ||
| 049 | |a DE-863 | ||
Record in the Search Index
| DE-BY-FWS_katkey | ZDB-4-EBA-on1202481001 |
|---|---|
| _version_ | 1829095342810857473 |
| adam_text | |
| any_adam_object | |
| author | Kumar, A. Bharath |
| author2 | Umashankar, M. S. |
| author2_role | |
| author2_variant | m s u ms msu |
| author_facet | Kumar, A. Bharath Umashankar, M. S. |
| author_role | |
| author_sort | Kumar, A. Bharath |
| author_variant | a b k ab abk |
| building | Verbundindex |
| bvnumber | localFWS |
| callnumber-first | R - Medicine |
| callnumber-label | RC667 |
| callnumber-raw | RC667 .K86 2020 |
| callnumber-search | RC667 .K86 2020 |
| callnumber-sort | RC 3667 K86 42020 |
| callnumber-subject | RC - Internal Medicine |
| collection | ZDB-4-EBA |
| contents | Cover -- Title -- Copyright -- End User License Agreement -- Contents -- Preface -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- Introduction to Heart Anatomy and Physiology -- INTRODUCTION -- Location of Heart -- Size and Shape of the Heart -- Chambers and Blood Circulation in the Heart -- Heart Chambers -- Blood Vessels -- Heart valves -- ANATOMY OF HEART -- Left Side of the Heart -- Right Side of the Heart -- Covering Layers of Heart -- The Internal Structural Pattern of the Heart -- Right Atrium -- Left Atrium -- Right Ventricle -- Left ventricle PHYSIOLOGY OF THE HEART -- Diastole -- Conduction System of the Heart -- Cardiac Cycle -- Relaxation Phase -- Blood Supply to Heart -- Heart Sounds -- Cardiac Output -- CONCLUSION -- REFERENCES -- Role of Biomarkers in Detection of Cardiovascular Diseases -- INTRODUCTION -- IDEAL CHARACTERISTICS OF BIOMARKERS -- MYOCARDIUM INJURY RISK PREDICTION BIOMARKERS -- Cardiac Troponin -- High-Sensitivity Cardiac Troponin (hs-cTn) -- Heart-Type Fatty Acid Binding Protein (H-FABP) -- INFLAMMATION PREDICTION BIOMARKERS -- High-Sensitivity C-reactive Protein (hs-CRP) Growth-Differentiation Factor-15 (GDF-15) -- Fibrinogen -- Uric Acid -- PLAQUES RUPTURE ASSESSMENT BIOMARKERS -- Myeloperoxidase (MPO) -- Matrix Metalloproteinases -- Pregnancy-Associated Plasma Protein-A (PAPP-A) -- Platelet Activation Biomarkers -- Secretory Phospholipase A2 (sPLA2) -- Lipoprotein-Associated Phospholipase A2 -- Soluble CD40 Ligand (sCD40L) -- BIOMARKERS OF NEUROHORMONAL ACTIVATION -- Mid-Regional-Pro-Adrenomedullin -- MYOCARDIAL DYSFUNCTION DETECTION BIOMARKERS ST -- Endothelin-1 (ET-1) -- Galectin-3 -- Neuregulin-1 -- BIOMARKERS OF MICRO RNAS (MIRNAS) OTHER BIOMARKERS INVOLVED IN THE PREDICTION OF CARDIOVASCULAR DISEASE RISK PREDICTION -- Neutrophil Gelatinase-Associated Lipocalin -- Natriuretic Peptides -- Apelin -- Growth Differentiation Factor-15 -- Cyclophilin A -- Prolactin -- Heart-type Fatty Acid Binding Protein (H-FABP) -- CONCLUSION -- REFERENCES -- Diagnostic Investigations for Detection of Cardiovascular Diseases -- INTRODUCTION -- CARDIOVASCULAR DISEASES: A GROUP OF DISORDERS OF THE HEART AND BLOOD VESSELS -- Coronary Heart Disease -- Cerebrovascular Disease -- Peripheral Arterial Disease -- Rheumatic Heart Disease Congenital Heart Disease -- Deep Vein Thrombosis and Pulmonary Embolism -- RISK FACTORS FOR CARDIOVASCULAR DISEASE -- DIAGNOSTIC INVESTIGATIONS FOR CARDIOVASCULAR DISEASES -- Blood Analysis -- Biomarkers for Detection of Cardiovascular Disease -- B-type Natriuretic Peptides -- Blood Urea Nitrogen -- C-reactive Protein -- Enzymes -- Fibrinogen -- Blood Sugar Test -- Homocysteine -- Lipid -- OTHER CARDIOVASCULAR DISEASE DIAGNOSTIC INVEST-IGATIONS -- CT Scan -- Cardiac Catheterization -- Echocardiography -- Ejection Fraction Testing -- Electrocardiogram -- Electrophysiology Study |
| ctrlnum | (OCoLC)1202481001 |
| dewey-full | 616.1/061 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.1/061 |
| dewey-search | 616.1/061 |
| dewey-sort | 3616.1 261 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>05827cam a2200553 i 4500</leader><controlfield tag="001">ZDB-4-EBA-on1202481001</controlfield><controlfield tag="003">OCoLC</controlfield><controlfield tag="005">20250103110447.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr cnu---unuuu</controlfield><controlfield tag="008">201031s2020 si o 000 0 eng d</controlfield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">EBLCP</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="e">pn</subfield><subfield code="c">EBLCP</subfield><subfield code="d">YDX</subfield><subfield code="d">N$T</subfield><subfield code="d">OCLCO</subfield><subfield code="d">N$T</subfield><subfield code="d">OCLCF</subfield><subfield code="d">YDX</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">K6U</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCL</subfield><subfield code="d">SXB</subfield><subfield code="d">CLOUD</subfield></datafield><datafield tag="019" ind1=" " ind2=" "><subfield code="a">1198713468</subfield><subfield code="a">1202448652</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9789811468216</subfield><subfield code="q">(electronic book)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9811468214</subfield><subfield code="q">(electronic book)</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1202481001</subfield><subfield code="z">(OCoLC)1198713468</subfield><subfield code="z">(OCoLC)1202448652</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RC667</subfield><subfield code="b">.K86 2020</subfield></datafield><datafield tag="082" ind1="7" ind2=" "><subfield code="a">616.1/061</subfield><subfield code="2">23</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">MAIN</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Kumar, A. Bharath.</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Pharmacotherapeutic Management of Cardiovascular Disease Complications :</subfield><subfield code="b">a textbook for medical students.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Singapore :</subfield><subfield code="b">Bentham Science Publishers,</subfield><subfield code="c">[2020]</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (361 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Cover -- Title -- Copyright -- End User License Agreement -- Contents -- Preface -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- Introduction to Heart Anatomy and Physiology -- INTRODUCTION -- Location of Heart -- Size and Shape of the Heart -- Chambers and Blood Circulation in the Heart -- Heart Chambers -- Blood Vessels -- Heart valves -- ANATOMY OF HEART -- Left Side of the Heart -- Right Side of the Heart -- Covering Layers of Heart -- The Internal Structural Pattern of the Heart -- Right Atrium -- Left Atrium -- Right Ventricle -- Left ventricle</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">PHYSIOLOGY OF THE HEART -- Diastole -- Conduction System of the Heart -- Cardiac Cycle -- Relaxation Phase -- Blood Supply to Heart -- Heart Sounds -- Cardiac Output -- CONCLUSION -- REFERENCES -- Role of Biomarkers in Detection of Cardiovascular Diseases -- INTRODUCTION -- IDEAL CHARACTERISTICS OF BIOMARKERS -- MYOCARDIUM INJURY RISK PREDICTION BIOMARKERS -- Cardiac Troponin -- High-Sensitivity Cardiac Troponin (hs-cTn) -- Heart-Type Fatty Acid Binding Protein (H-FABP) -- INFLAMMATION PREDICTION BIOMARKERS -- High-Sensitivity C-reactive Protein (hs-CRP)</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Growth-Differentiation Factor-15 (GDF-15) -- Fibrinogen -- Uric Acid -- PLAQUES RUPTURE ASSESSMENT BIOMARKERS -- Myeloperoxidase (MPO) -- Matrix Metalloproteinases -- Pregnancy-Associated Plasma Protein-A (PAPP-A) -- Platelet Activation Biomarkers -- Secretory Phospholipase A2 (sPLA2) -- Lipoprotein-Associated Phospholipase A2 -- Soluble CD40 Ligand (sCD40L) -- BIOMARKERS OF NEUROHORMONAL ACTIVATION -- Mid-Regional-Pro-Adrenomedullin -- MYOCARDIAL DYSFUNCTION DETECTION BIOMARKERS ST -- Endothelin-1 (ET-1) -- Galectin-3 -- Neuregulin-1 -- BIOMARKERS OF MICRO RNAS (MIRNAS)</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">OTHER BIOMARKERS INVOLVED IN THE PREDICTION OF CARDIOVASCULAR DISEASE RISK PREDICTION -- Neutrophil Gelatinase-Associated Lipocalin -- Natriuretic Peptides -- Apelin -- Growth Differentiation Factor-15 -- Cyclophilin A -- Prolactin -- Heart-type Fatty Acid Binding Protein (H-FABP) -- CONCLUSION -- REFERENCES -- Diagnostic Investigations for Detection of Cardiovascular Diseases -- INTRODUCTION -- CARDIOVASCULAR DISEASES: A GROUP OF DISORDERS OF THE HEART AND BLOOD VESSELS -- Coronary Heart Disease -- Cerebrovascular Disease -- Peripheral Arterial Disease -- Rheumatic Heart Disease</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Congenital Heart Disease -- Deep Vein Thrombosis and Pulmonary Embolism -- RISK FACTORS FOR CARDIOVASCULAR DISEASE -- DIAGNOSTIC INVESTIGATIONS FOR CARDIOVASCULAR DISEASES -- Blood Analysis -- Biomarkers for Detection of Cardiovascular Disease -- B-type Natriuretic Peptides -- Blood Urea Nitrogen -- C-reactive Protein -- Enzymes -- Fibrinogen -- Blood Sugar Test -- Homocysteine -- Lipid -- OTHER CARDIOVASCULAR DISEASE DIAGNOSTIC INVEST-IGATIONS -- CT Scan -- Cardiac Catheterization -- Echocardiography -- Ejection Fraction Testing -- Electrocardiogram -- Electrophysiology Study</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Cardiac Stress Test.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Pharmacotherapeutic Management of Cardiovascular Disease Complications is an essential textbook which comprehensively informs the reader about a broad variety of cardiovascular pathologies and their management through drug therapy. Key Features:- Features 22 chapters, with 17 chapters dedicated to the management of a wide range of cardiomyopathies and related complications- Introduces readers to heart anatomy and physiology, for both medical and pharmacology students- Covers information on cardiovascular disease biomarkers as well as current and new technologies for diagnostic procedures- Prov.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Cardiovascular system</subfield><subfield code="x">Diseases</subfield><subfield code="x">Chemotherapy.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Appareil cardiovasculaire</subfield><subfield code="x">Maladies</subfield><subfield code="x">Chimiothérapie.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cardiology.</subfield><subfield code="2">bisacsh/2013</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL.</subfield><subfield code="2">bisacsh/2013</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cardiovascular system</subfield><subfield code="x">Diseases</subfield><subfield code="x">Chemotherapy</subfield><subfield code="2">fast</subfield></datafield><datafield tag="655" ind1=" " ind2="0"><subfield code="a">Electronic books.</subfield></datafield><datafield tag="655" ind1=" " ind2="4"><subfield code="a">Electronic book.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Umashankar, M. S.</subfield></datafield><datafield tag="758" ind1=" " ind2=" "><subfield code="i">has work:</subfield><subfield code="a">Pharmacotherapeutic Management of Cardiovascular Disease Complications: A Textbook for Medical Students (Text)</subfield><subfield code="1">https://id.oclc.org/worldcat/entity/E39PCXjfjb6FtGtxJ4YdMYphgX</subfield><subfield code="4">https://id.oclc.org/worldcat/ontology/hasWork</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Print version:</subfield><subfield code="a">Umashankar, M.S.</subfield><subfield code="t">Pharmacotherapeutic Management of Cardiovascular Disease Complications: a Textbook for Medical Students.</subfield><subfield code="d">Singapore : Bentham Science Publishers, ©2020</subfield><subfield code="z">9789811468193</subfield></datafield><datafield tag="966" ind1="4" ind2="0"><subfield code="l">DE-862</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=2636075</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="4" ind2="0"><subfield code="l">DE-863</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=2636075</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">cloudLibrary</subfield><subfield code="b">CLDL</subfield><subfield code="n">9789811468216</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ProQuest Ebook Central</subfield><subfield code="b">EBLB</subfield><subfield code="n">EBL6371155</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">EBSCOhost</subfield><subfield code="b">EBSC</subfield><subfield code="n">2636075</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">YBP Library Services</subfield><subfield code="b">YANK</subfield><subfield code="n">301580035</subfield></datafield><datafield tag="994" ind1=" " ind2=" "><subfield code="a">92</subfield><subfield code="b">GEBAY</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-862</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-863</subfield></datafield></record></collection> |
| genre | Electronic books. Electronic book. |
| genre_facet | Electronic books. Electronic book. |
| id | ZDB-4-EBA-on1202481001 |
| illustrated | Not Illustrated |
| indexdate | 2025-04-11T08:47:30Z |
| institution | BVB |
| isbn | 9789811468216 9811468214 |
| language | English |
| oclc_num | 1202481001 |
| open_access_boolean | |
| owner | MAIN DE-862 DE-BY-FWS DE-863 DE-BY-FWS |
| owner_facet | MAIN DE-862 DE-BY-FWS DE-863 DE-BY-FWS |
| physical | 1 online resource (361 pages) |
| psigel | ZDB-4-EBA FWS_PDA_EBA ZDB-4-EBA |
| publishDate | 2020 |
| publishDateSearch | 2020 |
| publishDateSort | 2020 |
| publisher | Bentham Science Publishers, |
| record_format | marc |
| spelling | Kumar, A. Bharath. Pharmacotherapeutic Management of Cardiovascular Disease Complications : a textbook for medical students. Singapore : Bentham Science Publishers, [2020] 1 online resource (361 pages) text txt rdacontent computer c rdamedia online resource cr rdacarrier Cover -- Title -- Copyright -- End User License Agreement -- Contents -- Preface -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- Introduction to Heart Anatomy and Physiology -- INTRODUCTION -- Location of Heart -- Size and Shape of the Heart -- Chambers and Blood Circulation in the Heart -- Heart Chambers -- Blood Vessels -- Heart valves -- ANATOMY OF HEART -- Left Side of the Heart -- Right Side of the Heart -- Covering Layers of Heart -- The Internal Structural Pattern of the Heart -- Right Atrium -- Left Atrium -- Right Ventricle -- Left ventricle PHYSIOLOGY OF THE HEART -- Diastole -- Conduction System of the Heart -- Cardiac Cycle -- Relaxation Phase -- Blood Supply to Heart -- Heart Sounds -- Cardiac Output -- CONCLUSION -- REFERENCES -- Role of Biomarkers in Detection of Cardiovascular Diseases -- INTRODUCTION -- IDEAL CHARACTERISTICS OF BIOMARKERS -- MYOCARDIUM INJURY RISK PREDICTION BIOMARKERS -- Cardiac Troponin -- High-Sensitivity Cardiac Troponin (hs-cTn) -- Heart-Type Fatty Acid Binding Protein (H-FABP) -- INFLAMMATION PREDICTION BIOMARKERS -- High-Sensitivity C-reactive Protein (hs-CRP) Growth-Differentiation Factor-15 (GDF-15) -- Fibrinogen -- Uric Acid -- PLAQUES RUPTURE ASSESSMENT BIOMARKERS -- Myeloperoxidase (MPO) -- Matrix Metalloproteinases -- Pregnancy-Associated Plasma Protein-A (PAPP-A) -- Platelet Activation Biomarkers -- Secretory Phospholipase A2 (sPLA2) -- Lipoprotein-Associated Phospholipase A2 -- Soluble CD40 Ligand (sCD40L) -- BIOMARKERS OF NEUROHORMONAL ACTIVATION -- Mid-Regional-Pro-Adrenomedullin -- MYOCARDIAL DYSFUNCTION DETECTION BIOMARKERS ST -- Endothelin-1 (ET-1) -- Galectin-3 -- Neuregulin-1 -- BIOMARKERS OF MICRO RNAS (MIRNAS) OTHER BIOMARKERS INVOLVED IN THE PREDICTION OF CARDIOVASCULAR DISEASE RISK PREDICTION -- Neutrophil Gelatinase-Associated Lipocalin -- Natriuretic Peptides -- Apelin -- Growth Differentiation Factor-15 -- Cyclophilin A -- Prolactin -- Heart-type Fatty Acid Binding Protein (H-FABP) -- CONCLUSION -- REFERENCES -- Diagnostic Investigations for Detection of Cardiovascular Diseases -- INTRODUCTION -- CARDIOVASCULAR DISEASES: A GROUP OF DISORDERS OF THE HEART AND BLOOD VESSELS -- Coronary Heart Disease -- Cerebrovascular Disease -- Peripheral Arterial Disease -- Rheumatic Heart Disease Congenital Heart Disease -- Deep Vein Thrombosis and Pulmonary Embolism -- RISK FACTORS FOR CARDIOVASCULAR DISEASE -- DIAGNOSTIC INVESTIGATIONS FOR CARDIOVASCULAR DISEASES -- Blood Analysis -- Biomarkers for Detection of Cardiovascular Disease -- B-type Natriuretic Peptides -- Blood Urea Nitrogen -- C-reactive Protein -- Enzymes -- Fibrinogen -- Blood Sugar Test -- Homocysteine -- Lipid -- OTHER CARDIOVASCULAR DISEASE DIAGNOSTIC INVEST-IGATIONS -- CT Scan -- Cardiac Catheterization -- Echocardiography -- Ejection Fraction Testing -- Electrocardiogram -- Electrophysiology Study Cardiac Stress Test. Pharmacotherapeutic Management of Cardiovascular Disease Complications is an essential textbook which comprehensively informs the reader about a broad variety of cardiovascular pathologies and their management through drug therapy. Key Features:- Features 22 chapters, with 17 chapters dedicated to the management of a wide range of cardiomyopathies and related complications- Introduces readers to heart anatomy and physiology, for both medical and pharmacology students- Covers information on cardiovascular disease biomarkers as well as current and new technologies for diagnostic procedures- Prov. Cardiovascular system Diseases Chemotherapy. Appareil cardiovasculaire Maladies Chimiothérapie. Cardiology. bisacsh/2013 MEDICAL. bisacsh/2013 Cardiovascular system Diseases Chemotherapy fast Electronic books. Electronic book. Umashankar, M. S. has work: Pharmacotherapeutic Management of Cardiovascular Disease Complications: A Textbook for Medical Students (Text) https://id.oclc.org/worldcat/entity/E39PCXjfjb6FtGtxJ4YdMYphgX https://id.oclc.org/worldcat/ontology/hasWork Print version: Umashankar, M.S. Pharmacotherapeutic Management of Cardiovascular Disease Complications: a Textbook for Medical Students. Singapore : Bentham Science Publishers, ©2020 9789811468193 |
| spellingShingle | Kumar, A. Bharath Pharmacotherapeutic Management of Cardiovascular Disease Complications : a textbook for medical students. Cover -- Title -- Copyright -- End User License Agreement -- Contents -- Preface -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- Introduction to Heart Anatomy and Physiology -- INTRODUCTION -- Location of Heart -- Size and Shape of the Heart -- Chambers and Blood Circulation in the Heart -- Heart Chambers -- Blood Vessels -- Heart valves -- ANATOMY OF HEART -- Left Side of the Heart -- Right Side of the Heart -- Covering Layers of Heart -- The Internal Structural Pattern of the Heart -- Right Atrium -- Left Atrium -- Right Ventricle -- Left ventricle PHYSIOLOGY OF THE HEART -- Diastole -- Conduction System of the Heart -- Cardiac Cycle -- Relaxation Phase -- Blood Supply to Heart -- Heart Sounds -- Cardiac Output -- CONCLUSION -- REFERENCES -- Role of Biomarkers in Detection of Cardiovascular Diseases -- INTRODUCTION -- IDEAL CHARACTERISTICS OF BIOMARKERS -- MYOCARDIUM INJURY RISK PREDICTION BIOMARKERS -- Cardiac Troponin -- High-Sensitivity Cardiac Troponin (hs-cTn) -- Heart-Type Fatty Acid Binding Protein (H-FABP) -- INFLAMMATION PREDICTION BIOMARKERS -- High-Sensitivity C-reactive Protein (hs-CRP) Growth-Differentiation Factor-15 (GDF-15) -- Fibrinogen -- Uric Acid -- PLAQUES RUPTURE ASSESSMENT BIOMARKERS -- Myeloperoxidase (MPO) -- Matrix Metalloproteinases -- Pregnancy-Associated Plasma Protein-A (PAPP-A) -- Platelet Activation Biomarkers -- Secretory Phospholipase A2 (sPLA2) -- Lipoprotein-Associated Phospholipase A2 -- Soluble CD40 Ligand (sCD40L) -- BIOMARKERS OF NEUROHORMONAL ACTIVATION -- Mid-Regional-Pro-Adrenomedullin -- MYOCARDIAL DYSFUNCTION DETECTION BIOMARKERS ST -- Endothelin-1 (ET-1) -- Galectin-3 -- Neuregulin-1 -- BIOMARKERS OF MICRO RNAS (MIRNAS) OTHER BIOMARKERS INVOLVED IN THE PREDICTION OF CARDIOVASCULAR DISEASE RISK PREDICTION -- Neutrophil Gelatinase-Associated Lipocalin -- Natriuretic Peptides -- Apelin -- Growth Differentiation Factor-15 -- Cyclophilin A -- Prolactin -- Heart-type Fatty Acid Binding Protein (H-FABP) -- CONCLUSION -- REFERENCES -- Diagnostic Investigations for Detection of Cardiovascular Diseases -- INTRODUCTION -- CARDIOVASCULAR DISEASES: A GROUP OF DISORDERS OF THE HEART AND BLOOD VESSELS -- Coronary Heart Disease -- Cerebrovascular Disease -- Peripheral Arterial Disease -- Rheumatic Heart Disease Congenital Heart Disease -- Deep Vein Thrombosis and Pulmonary Embolism -- RISK FACTORS FOR CARDIOVASCULAR DISEASE -- DIAGNOSTIC INVESTIGATIONS FOR CARDIOVASCULAR DISEASES -- Blood Analysis -- Biomarkers for Detection of Cardiovascular Disease -- B-type Natriuretic Peptides -- Blood Urea Nitrogen -- C-reactive Protein -- Enzymes -- Fibrinogen -- Blood Sugar Test -- Homocysteine -- Lipid -- OTHER CARDIOVASCULAR DISEASE DIAGNOSTIC INVEST-IGATIONS -- CT Scan -- Cardiac Catheterization -- Echocardiography -- Ejection Fraction Testing -- Electrocardiogram -- Electrophysiology Study Cardiovascular system Diseases Chemotherapy. Appareil cardiovasculaire Maladies Chimiothérapie. Cardiology. bisacsh/2013 MEDICAL. bisacsh/2013 Cardiovascular system Diseases Chemotherapy fast |
| title | Pharmacotherapeutic Management of Cardiovascular Disease Complications : a textbook for medical students. |
| title_auth | Pharmacotherapeutic Management of Cardiovascular Disease Complications : a textbook for medical students. |
| title_exact_search | Pharmacotherapeutic Management of Cardiovascular Disease Complications : a textbook for medical students. |
| title_full | Pharmacotherapeutic Management of Cardiovascular Disease Complications : a textbook for medical students. |
| title_fullStr | Pharmacotherapeutic Management of Cardiovascular Disease Complications : a textbook for medical students. |
| title_full_unstemmed | Pharmacotherapeutic Management of Cardiovascular Disease Complications : a textbook for medical students. |
| title_short | Pharmacotherapeutic Management of Cardiovascular Disease Complications : |
| title_sort | pharmacotherapeutic management of cardiovascular disease complications a textbook for medical students |
| title_sub | a textbook for medical students. |
| topic | Cardiovascular system Diseases Chemotherapy. Appareil cardiovasculaire Maladies Chimiothérapie. Cardiology. bisacsh/2013 MEDICAL. bisacsh/2013 Cardiovascular system Diseases Chemotherapy fast |
| topic_facet | Cardiovascular system Diseases Chemotherapy. Appareil cardiovasculaire Maladies Chimiothérapie. Cardiology. MEDICAL. Cardiovascular system Diseases Chemotherapy Electronic books. Electronic book. |
| work_keys_str_mv | AT kumarabharath pharmacotherapeuticmanagementofcardiovasculardiseasecomplicationsatextbookformedicalstudents AT umashankarms pharmacotherapeuticmanagementofcardiovasculardiseasecomplicationsatextbookformedicalstudents |